CDT Equity announces 1-for-10 reverse stock split to maintain Nasdaq listing compliance

Conduit Pharmaceuticals

Conduit Pharmaceuticals

CDT

0.00
  • CDT Equity will implement a 1-for-10 reverse stock split to support compliance with Nasdaq’s minimum bid-price requirement.
  • Split takes effect July 17 at 5:00 p.m. ET; trading on a split-adjusted basis begins July 20 on Nasdaq under CDT.
  • Outstanding shares to fall to about 631,077; fractional shares replaced with cash payments.
  • New CUSIP 20678X601; par value stays at USD 0.0001 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160800PRIMZONEFULLFEED9763313) on July 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.